Brief: Lexaria Bioscience Received Letter Confirming The Cure Of Nasdaq Bid Price Deficiency
28/08/2023 19:52
Aug 28 (Reuters) - Lexaria Bioscience Corp LEXX.O :
* LEXARIA BIOSCIENCE CORP - ON AUGUST 24, CO RECEIVED A LETTER FROM NASDAQ
CONFIRMING THE CURE OF NASDAQ BID PRICE DEFICIENCY
Source text for Eikon: ID:
Further company coverage: LEXX.O
((Reuters.Briefs@thomsonreuters.com;))